DTX2 and central nervous system cancer: The results showed upregulation of HLTF expression in glioma cells with DTX2 knockdown and downregulation in the DTX2-overexpressing U87 and U251 cells (Fig. 4C), indicating a negative regulation between DTX2 and HLTF.